LEERINK PARTNERS
Leerink Partners is a leading investment bank, specializing in healthcare. Their knowledge, experience and focus enable us to help their clients define and achieve their strategic, capital markets and investment objectives. They partner with companies that develop and commercialize innovative products and services that are defining the future of healthcare.
LEERINK PARTNERS
Industry:
Banking Health Care
Founded:
1995-01-01
Status:
Active
Contact:
(800) 808-7525
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
SSL By Default Font Awesome Apache ReCAPTCHA Microsoft GoDaddy SSL Gravity Forms IIS 8 ASP.NET Ajax Google Maps For Work
Similar Organizations
Accelerator Group
Accelerator Group is an investment banking Advisory services and Knowledge Services firm.
Macquarie Group
Macquarie Group is a global provider of banking, financial, advisory, investment and funds management services.
Moda Health
Moda Health offers quality health coverage in Oregon, Washington, and Alaska.
Current Advisors List
Current Employees Featured
Founder
Investors List
Lovell Minnick Partners
Lovell Minnick Partners investment in Private Equity Round - Leerink Partners
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2020-08-26 | Kinnate Biopharma | Leerink Partners investment in Series C - Kinnate Biopharma | 98 M USD |
| 2019-05-23 | AlloVir | Leerink Partners investment in Series B - AlloVir | 120 M USD |
| 2018-09-05 | Fulcrum Therapeutics | Leerink Partners investment in Series B - Fulcrum Therapeutics | 80 M USD |
| 2018-06-08 | Precision BioSciences | Leerink Partners investment in Series B - Precision BioSciences | 110 M USD |
| 2018-05-16 | FogPharma | Leerink Partners investment in Series B - FogPharma | 66 M USD |
| 2018-02-27 | Generation Bio | Leerink Partners investment in Series B - Generation Bio | 100 M USD |
| 2018-02-01 | Avrobio | Leerink Partners investment in Series B - Avrobio | 60 M USD |
| 2017-11-13 | Arcus Biosciences | Leerink Partners investment in Series C - Arcus Biosciences | 107 M USD |
| 2017-09-08 | Replimune Group | Leerink Partners investment in Series B - Replimune Group | 55 M USD |
| 2017-03-30 | Solid Biosciences | Leerink Partners investment in Series C - Solid Biosciences | 50 M USD |
Newest Events participated
Participated in 3rd Annual NEVY Awards
on 2015-05-13 as sponsor
Key Employee Changes
| Date | New article |
|---|---|
| 2021-10-14 | Immunic, Inc. Appoints Patrick Walsh as Chief Business Officer |
More informations about "Leerink Partners"
The Healthcare Investment Bank - Leerink Partners
For three decades, Leerink has partnered with visionaries who are shaping the future of healthcare. We provide financial solutions that help innovators develop new therapeutics, …See details»
Leerink Partners - Wikipedia
Leerink Partners was founded in 1995 as Leerink Swann LLC. The following year, the bank established MEDACorp expert network as a joint venture with Dr. Dan Dubin. It acted as a strategic knowledge resource at Leerink, using validation of new products and commercial viability in the assessment of company financials, and corporate due diligence in the medial field as part of a merger and acquisition advisory or capital raising. See details»
Firm - Leerink Partners
Since its founding three decades ago, Leerink Partners has emerged as a leading investment bank known for its expertise in equity research, equity capital markets, and M&A.See details»
Leerink Partners - LinkedIn
Leerink Partners is a leading investment bank providing a complete suite of financial solutions comprising M&A advisory, equity, debt, and derivative capital markets, equity research, and sales...See details»
Leerink Partners - The Org
Leerink Partners is a leading investment bank providing a complete suite of financial solutions comprising M&A advisory, equity, debt, and derivative capital markets, equity research, and …See details»
Justin Reed | Leerink Partners
Justin Reed is a Managing Director at Leerink Partners where he is focused on advising companies in the medical device sector on M&A and public and private equity offerings. Prior to joining the Firm in 2024, Justin was most recently …See details»
Leerink Partners - Crunchbase Investor Profile & Investments
Leerink Partners is a leading investment bank, specializing in healthcare. Their knowledge, experience and focus enable us to help their clients define and achieve their strategic, capital …See details»
SVB Financial Group - SVB Financial Group Completes Acquisition …
Jan 4, 2019 · SVB Financial Group ("SVB") (NASDAQ: SIVB), the parent company of Silicon Valley Bank , today announced it has completed the acquisition of Leerink Holdings LLC , the …See details»
Leerink: The Company That Bounced Back from an SVB Demerger
Oct 31, 2024 · Among the institutions caught in the storm was Leerink Partners, a key player in the healthcare investment banking space. Once under SVB’s ownership from 2019 until the …See details»
Leerink: The Company That Bounced Back from an SVB Demerger
Oct 31, 2024 · On 10th March 2023, Silicon Valley Bank (SVB) collapsed, marking one of the largest bank failures in US history and sending shockwaves through the innovation economy. …See details»
Leerink Partners - Leadership Team - The Org
The Leadership Team at Leerink Partners drives the strategic vision and operational effectiveness of the firm, leveraging their extensive expertise in healthcare investment banking.See details»
Leerink Partners Sticks to Their Buy Rating for Penumbra (PEN)
7 hours ago · In a report released on November 25, Mike Kratky from Leerink Partners maintained a Buy rating on Penumbra (PEN – Research Report), with a price target of $262.00. The …See details»
Org Chart Leerink Partners - The Official Board
The organizational chart of Leerink Partners displays its 32 main executives including Jeffrey Leerink, Tom Davidson and Jim KellySee details»
Leerink Partners Keeps Their Buy Rating on Insulet (PODD)
7 hours ago · Leerink Partners analyst Mike Kratky maintained a Buy rating on Insulet (PODD – Research Report) on November 25 and set a price target of $290.00. The company’s shares …See details»
Jason Truman | Leerink Partners
Jason Truman is a Senior Managing Director at Leerink Partners focused on Biopharma Mergers & Acquisitions. Prior to joining the Firm in 2024, Jason most recently was Senior Managing …See details»
Hanoi - KPMG Vietnam
For more detail about the structure of the KPMG global organization please visit https://kpmg.com/governance.See details»
Leerink Partners Keeps Their Buy Rating on Tandem Diabetes Care …
7 hours ago · Leerink Partners analyst Mike Kratky maintained a Buy rating on Tandem Diabetes Care (TNDM – Research Report) on November 25 and set a price target of $58.00. The …See details»
Faisal Khurshid | Leerink Partners
Faisal A. Khurshid is a Senior Research Analyst at Leerink Partners leading our Emerging Immunology sector. Prior to joining the firm in 2021, Faisal worked as a consultant to several …See details»
ECA and partners celebrates the second World Sustainable …
2 days ago · Addis Ababa, 26 November 2023 (ECA) - To mark the 2 nd World Sustainable Transport Day, the United Nations Economic Commission for Africa (ECA) in collaboration …See details»
Tòa nhà HH4 Tower (Tòa nhà Sông Đà), Mỹ Đình, Q. Nam Từ Liêm
HH4 Sông Đà Mỹ Đình là tòa nhà văn phòng cho thuê, kết hợp khối dịch vụ nằm trong khu đô thị mới Mỹ Đình - Mễ Trì, được đầu tư bởi Tập đoàn Sông Đà. Đây cũng là trụ sở làm việc chính …See details»